BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 18272302)

  • 1. Silicate release from glass for pharmaceutical preparations.
    Bohrer D; Bortoluzzi F; Nascimento PC; Carvalho LM; Ramirez AG
    Int J Pharm; 2008 May; 355(1-2):174-83. PubMed ID: 18272302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low availability of aluminum in formulations for parenteral nutrition containing silicate.
    Bohrer D; Bortoluzzi F; do Nascimento PC; de Carvalho LM; de Oliveira SR
    JPEN J Parenter Enteral Nutr; 2009; 33(6):694-701. PubMed ID: 19587384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical evaluation of the standard hydrolytic resistance test for glasses used for containers for blood and parenteral formulations.
    Bohrer D; Do Nascimento PC; Becker E; Bortoluzzi F; Depoi F; de Carvalho LM
    PDA J Pharm Sci Technol; 2004; 58(2):96-105. PubMed ID: 15113075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic release from glass containers by action of intravenous nutrition formulation constituents.
    Bohrer D; Becker E; Nascimento PC; Mörschbächer V; de Carvalho LM; da Silva Marques M
    Int J Pharm; 2006 Jun; 315(1-2):24-9. PubMed ID: 16621370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.
    Biavati A; Poncini M; Ferrarini A; Favaro N; Scarpa M; Vallotto M
    PDA J Pharm Sci Technol; 2017; 71(4):306-316. PubMed ID: 28747538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part II: amino acids for parenteral nutrition.
    Bohrer D; do Nascimento PC; Binotto R; Carlesso R
    J Trace Elem Med Biol; 2001; 15(2-3):103-8. PubMed ID: 11787973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: Interaction container-chemicals during the heating for sterilisation.
    Bohrer D; do Nascimento PC; Binotto R; Becker E
    J Trace Elem Med Biol; 2003; 17(2):107-15. PubMed ID: 14531639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Contribution to an Understanding of Complexing Agents and Salt Solutions Reaction Mechanism on Chemical Attack of Type I Molded Glass Containers.
    Biavati A; Severi G; Bisceglie F; Marchegiani M; Ferrarini A
    PDA J Pharm Sci Technol; 2019; 73(6):538-551. PubMed ID: 31101704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and phosphorus compatibility in parental nutrition solutions for neonates.
    Eggert LD; Rusho WJ; MacKay MW; Chan GM
    Am J Hosp Pharm; 1982 Jan; 39(1):49-53. PubMed ID: 6798868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Container effects on the physicochemical properties of parenteral lipid emulsions.
    Gonyon T; Carter PW; Dahlem O; Denet AR; Owen H; Trouilly JL
    Nutrition; 2008; 24(11-12):1182-8. PubMed ID: 18707847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media.
    Guadagnino E; Zuccato D
    PDA J Pharm Sci Technol; 2012; 66(2):116-25. PubMed ID: 22492597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum and Phthalates in Calcium Gluconate: Contribution From Glass and Plastic Packaging.
    Yokel RA; Unrine JM
    J Pediatr Gastroenterol Nutr; 2017 Jan; 64(1):109-114. PubMed ID: 27111341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part I: salts, glucose, heparin and albumin.
    Bohrer D; do Nascimento PC; Binotto R; Pomblum SC
    J Trace Elem Med Biol; 2001; 15(2-3):95-101. PubMed ID: 11787994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and chemical stability of paclitaxel infusions in different container types.
    Donyai P; Sewell GJ
    J Oncol Pharm Pract; 2006 Dec; 12(4):211-22. PubMed ID: 17156593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particulate contamination and stability of three additives in 0.9% sodium chloride injection in plastic and glass large-volume containers.
    Stokes TF; Sumner ED; Needham TE
    Am J Hosp Pharm; 1975 Aug; 32(8):821-6. PubMed ID: 1146840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic species in solutions for parenteral nutrition.
    Bohrer D; do Nascimento PC; Becker E; de Carvalho LM; Dessuy M
    JPEN J Parenter Enteral Nutr; 2005; 29(1):1-7. PubMed ID: 15715267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of primary packaging on the quality of parenteral products.
    Solomun L; Ibric S; Boltic Z; Djuric Z; Stupar B
    J Pharm Biomed Anal; 2008 Nov; 48(3):744-8. PubMed ID: 18786797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium silicate as alternative to liming-reduced aluminium toxicity for Atlantic salmon (Salmo salar L.) in unstable mixing zones.
    Teien HC; Kroglund F; Atland A; Rosseland BO; Salbu B
    Sci Total Environ; 2006 Apr; 358(1-3):151-63. PubMed ID: 16225906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteric-coated solid dosage forms containing sodium bicarbonate as a drug substance: an exception from the rule?
    Breitkreutz J; Gan TG; Schneider B; Kalisch P
    J Pharm Pharmacol; 2007 Jan; 59(1):59-65. PubMed ID: 17227621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.